Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 1, Issue 6, pp. 496-507
PubMed
Published By
Print ISSN
Online ISSN
History
- Received June 19, 2011
- Revision received August 23, 2011
- Accepted September 13, 2011
- Published first September 15, 2011.
Article Versions
- Previous version (September 15, 2011 - 10:12).
- Previous version (November 4, 2011 - 09:21).
- Previous version (November 9, 2011 - 07:47).
- You are viewing the most recent version of this article.
Copyright & Usage
©2011 American Association for Cancer Research.
Author Information
- Thomas Enzler1,5,6,*,
- Yasuyo Sano1,*,
- Min-Kyung Choo1,*,
- Howard B. Cottam7,
- Michael Karin6,
- Hensin Tsao2,3,4 and
- Jin Mo Park1,4
- Authors' Affiliations: 1Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown; 2Wellman Center for Photomedicine, 3MGH Cancer Center, and 4Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; 5Department of Hematology and Oncology, University Medicine Goettingen, Goettingen, Germany; and 6Department of Pharmacology, School of Medicine, and 7Moores Cancer Center, University of California, San Diego, La Jolla, California
- Corresponding Author:
Jin Mo Park, Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, 149 Thirteenth Street, Charlestown, MA 02129. Phone: 617-643-2328; Fax: 617-726-4453; E-mail: jmpark{at}cbrc2.mgh.harvard.edu
↵* These authors contributed equally to this work.
November 2011
Volume 1, Issue 6
Volume 1, Issue 6
Cell-Selective Inhibition of NF-κB Signaling Improves Therapeutic Index in a Melanoma Chemotherapy Model
Jump to section
Advertisement